Recombinant Human IGF2R Protein，His

IGF2R (Insulin-like Growth Factor 2 Receptor) is a critical component in the regulation of growth and development, primarily by mediating the actions of insulin-like growth factor 2 (IGF2). The receptor plays a vital role in cellular processes such as growth factor signaling, endocytosis, and the regulation of gene expression. Its involvement in various physiological conditions, including fetal development, metabolic disorders, and cancer, has spurred significant interest in its therapeutic potential. The interest in IGF2R as a target for drug development is heightened by findings that alterations in its expression or function are linked to various pathologies, including obesity, diabetes, and different types of cancer. Moreover, IGF2R exhibits an intricate relationship with other signaling pathways, suggesting that its modulation could have widespread implications for treatment strategies. Research on recombinant IGF2R protein offers promising avenues for exploring its structure-function relationships and developing potential biomarker applications. By producing recombinant IGF2R, researchers can investigate its binding properties, signaling mechanisms, and interactions with IGF2 and other ligands. This could lead to the development of novel therapeutic agents aimed at modulating IGF2R function to combat associated diseases. As such, the ongoing research into recombinant IGF2R protein is vital for elucidating its biological roles and therapeutic applications, potentially paving the way for innovative interventions in metabolic and oncological disorders.